Cbd Rich Chemotype

CBD-rich chemotypes represent cannabis plants bred to produce significant cannabidiol (CBD) alongside variable THC levels, typically through selective breeding of cultivars expressing the recessive cbd allele. Lineage records frequently report CBD-rich genetics emerging from European breeding programs, hemp cultivars, and crosses with high-CBD phenotypes discovered in traditional landrace populations. These chemotypes are characterized by a different cannabinoid profile than THC-dominant varieties, with CBD often comprising 4% or more of total cannabinoids. Breeders working in this category focus on stabilizing CBD expression while managing THC ratios to meet regulatory or market-specific requirements. The genetic basis involves different enzymatic pathways that prioritize CBDA synthase activity over THCA synthase, creating distinct plant chemistry from conception.

Breeders select for CBD-rich chemotypes through phytochemical testing and controlled crosses between high-CBD parents, aiming to create stable F1 and IBL lines for consistent cannabinoid expression across generations. CBD-rich genetics are foundational in developing cultivars for jurisdictions with specific cannabinoid ratio requirements.